Orchid Pharma Limited, a pharmaceutical company, engages in the development, manufacture, and marketing of pharmaceutical products in India and internationally. The company's active pharmaceutical ingredients product portfolio includes oral cephalosporins, injectable cephalosporins, veterinary products, and non-antibiotics; and formulations comprising cardiovascular, anti-diabetic, neuropsychiatry, nutritional supplements, and other products. It also provides anti-infectives, anti-inflammatory, central nervous system, cardio vascular segment, nutraceuticals, and other oral and sterile products, as well as offers new drug discovery systems, novel drug delivery systems, and contract research and manufacturing services. The company was formerly known as Orchid Chemicals & Pharmaceuticals Limited and changed its name to Orchid Pharma Limited in October 2015. Orchid Pharma Limited was founded in 1992 and is headquartered in Chennai, India. The ISIN of this stock is INE191A01027.